Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · IEX Real-Time Price · USD
16.40
+0.10 (0.61%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $861.34 million as of March 28, 2024. Its market cap has increased by 27.81% in one year.
Market Cap
861.34M
Enterprise Value
663.37M
1-Year Change
27.81%
Ranking
Category
Stock Price
$16.40
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $861.34M, an increase of 31.57%. That is a compound annual growth rate of 11.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 856.10M | 0.93% |
Mar 26, 2024 | 848.20M | -1.94% |
Mar 25, 2024 | 865.00M | -1.50% |
Mar 22, 2024 | 878.20M | -0.06% |
Mar 21, 2024 | 878.70M | -3.68% |
Mar 20, 2024 | 912.30M | 7.89% |
Mar 19, 2024 | 845.60M | 21.01% |
Mar 18, 2024 | 698.80M | -7.26% |
Mar 15, 2024 | 753.50M | -1.41% |
Mar 14, 2024 | 764.30M | -5.28% |
Mar 13, 2024 | 806.90M | -0.90% |
Mar 12, 2024 | 814.20M | -3.03% |
Mar 11, 2024 | 839.60M | -0.87% |
Mar 8, 2024 | 847.00M | 0.88% |
Mar 7, 2024 | 839.60M | -1.12% |
Mar 6, 2024 | 849.10M | 1.59% |
Mar 5, 2024 | 835.80M | -2.95% |
Mar 4, 2024 | 861.20M | 0.35% |
Mar 1, 2024 | 858.20M | -0.29% |
Feb 29, 2024 | 860.70M | 0.44% |
Feb 28, 2024 | 856.90M | 1.17% |
Feb 27, 2024 | 847.00M | 1.56% |
Feb 26, 2024 | 834.00M | 0.52% |
Feb 23, 2024 | 829.70M | 2.12% |
Feb 22, 2024 | 812.50M | -1.87% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Avanos Medical | 900.98M |
MacroGenics | 899.65M |
Healthcare Services Group | 894.03M |
Alignment Healthcare | 874.97M |
Pliant Therapeutics | 865.03M |
Quanterix | 855.29M |
Cassava Sciences | 851.54M |
Evolus | 848.67M |